Detection of bacterial pyrogens on the basis of their effects on gamma interferon-mediated formation of neopterin or nitrite in cultured monocyte cell lines.
In a number of mammalian cell types, pteridine biosynthesis from guanosine 5'-triphosphate and formation of nitric oxide from L-arginine are induced by gamma interferon (IFN-gamma) and bacterial lipopolysaccharide (LPS). We assessed the possibility of using such metabolic alterations for the in vitro detection of pyrogens. Products from gram-negative and gram-positive bacteria and related synthetic compounds were tested for their potential to induce either of these pathways. Stimulation of pteridine biosynthesis was monitored as the formation of neopterin in the human myelomonocytic cell line THP-1. The formation of nitric oxide was determined as nitrite in murine J774A.1 macrophage cultures. The substances tested included toxic and detoxified parts of LPS and lipid A from Escherichia coli, Salmonella typhimurium, Salmonella minnesota, and Klebsiella pneumoniae as well as lipoteichoic acid and toxic shock syndrome toxin 1 from Staphylococcus aureus. Furthermore, two cell wall compounds from Mycobacterium tuberculosis, trehalose 6,6'-dimycolate and N-acetylmuramyl-L-alanyl-D-isoglutamine, which are active components of Freund's adjuvant, were used. When applied as a single stimulus, only the whole LPS molecule potently stimulated neopterin or nitrite formation. Lipid A and products from gram-positive bacteria were weakly active. For neopterin formation, lipid A required the presence of fetal calf serum. Besides detoxified LPS and independently from the presence of serum, all bacterial compounds tested strongly increased the effects mediated by IFN-gamma. Our results show that bacterial pyrogens can be detected by monitoring the formation of neopterin or nitrite. This may provide a basis for the development of an in vitro assay for the detection of pyrogenic contamination with the aim of replacing the currently used animal test.
Werner-Felmayer
G
G
Institute for Medical Chemistry and Biochemistry, University of Innsbruck, Austria.
Baier-Bitterlich
G
G
Fuchs
D
D
Hausen
A
A
Murr
C
C
Reibnegger
G
G
Werner
E R
ER
Wachter
H
H
D000818:Animals; D001426:Bacterial Proteins / Q000302:isolation & purification / Q000378:metabolism; D001708:Biopterins / Q000031:analogs & derivatives* / Q000096:biosynthesis; D002460:Cell Line; D004731:Endotoxins / Q000378:metabolism; D006801:Humans; D007371:Interferon-gamma / Q000187:drug effects / Q000494:pharmacology*; D008070:Lipopolysaccharides / Q000302:isolation & purification; D008264:Macrophages / Q000378:metabolism; D051379:Mice; D009000:Monocytes / Q000378:metabolism; D019798:Neopterin; D009573:Nitrites / Q000378:metabolism*; D011621:Pteridines / Q000378:metabolism*; D011749:Pyrogens / Q000378:metabolism / Q000494:pharmacology*; D012486:Salmonella typhimurium / Q000378:metabolism; D014407:Tumor Cells, Cultured / Q000378:metabolism
D001426:Bacterial Proteins; D004731:Endotoxins; D008070:Lipopolysaccharides; D009573:Nitrites; D011621:Pteridines; D011749:Pyrogens; D001708:Biopterins; D019798:Neopterin; D007371:Interferon-gamma